Literature DB >> 8816133

Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS.

M C Rodriguez-Barradas1, E Stool, D M Musher, J Gathe, J Goldstein, R M Genta, B Yoffe.   

Abstract

Because cytomegalovirus (CMV) can be isolated from pulmonary secretions of human immunodeficiency virus (HIV)-infected patients without causing disease, its clinical significance as a cause of pneumonia in this patient population is frequently questioned. In a 22-month period, CMV pneumonia was diagnosed in 17 (8%) of 210 HIV-infected patients who underwent lung biopsy on the basis of microbiological and histologic criteria. The clinical presentations of these patients were nonspecific, including fever (100% of patients), shortness of breath (71%), cough (76%), and Pao2 of < 75 mm Hg (88%). A high correlation in the degree of viral burden in lung biopsy specimens was demonstrated by histologic examination, immunohistochemical analysis, and in situ hybridization. No other pulmonary pathogens were identified for nine patients, whereas other possible causes of pneumonia were present in eight: 11 patients had evidence of extrapulmonary CMV disease at presentation. Most patients initially responded to specific anti-CMV therapy; the overall mean survival +/- SD was 3.1 +/- 2.5 months. CMV should be considered as a possible cause of pneumonia in patients with advanced AIDS especially if CMV infection is documented at other sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816133     DOI: 10.1093/clinids/23.1.76

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

Authors:  C Binquet; F Saillour; N Bernard; M B Rougier; F Leger; F Bonnal; F Dabis
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

2.  Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS.

Authors:  S A Spector; K Hsia; M Crager; M Pilcher; S Cabral; M J Stempien
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 3.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

Review 4.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

Review 5.  HIV-associated opportunistic pneumonias.

Authors:  Laurence Huang; Kristina Crothers
Journal:  Respirology       Date:  2009-05       Impact factor: 6.424

6.  A 26 year-old woman with AIDS and pneumonia.

Authors:  Amir Yousefzadeh; Atosa Dorudinia; Sayena Jabbehdari; Majid Marjani; Afshin Moniri; Parvaneh Baghaei; Hamidreza Jabbar Darjani; Payam Tabarsi
Journal:  Tanaffos       Date:  2013

7.  Acute cytomegalovirus pneumonia and hepatitis presenting during acute HIV retroviral syndrome.

Authors:  K-W Hong; S I Kim; Y J Kim; S H Wie; Y R Kim; J-H Yoo; N I Han; M W Kang
Journal:  Infection       Date:  2011-01-19       Impact factor: 7.455

8.  Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.

Authors:  Avirup Chakraborty; Tanmay Mahapatra; Sanchita Mahapatra; Sabbir Ansari; Sattik Siddhanta; Siwalik Banerjee; Dipanjan Banerjee; Rathindra Nath Sarkar; Subhashish Kamal Guha; Nilanjan Chakraborty
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

9.  A rare case of CMV pneumonia in HIV-infection.

Authors:  Kai Chin Poh; Shuwei Zheng
Journal:  Respir Med Case Rep       Date:  2019-10-16

10.  A 60 year-old man with AIDS and pneumonia.

Authors:  Payam Tabarsi; Amir Yousefzadeh; Atosa Dorudinia; Majid Marjani; Afshin Moniri; Seyed Alireza Nadji; Parvaneh Baghaei; Sayena Jabbedari; Davood Mansouri
Journal:  Tanaffos       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.